Study Comparing Product 0405 to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Subjects

NCT02176551 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Business Reasons

Conditions

Atopic Dermatitis

Interventions

DRUG: Product 0405
DRUG: Placebo for Product 0405

Sponsor

Fougera Pharmaceuticals Inc.